Is nosocomial infection really the major cause of death in sepsis?

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Goldenberg, Neil M ^a   Leligdowicz, Aleksandra ^b   Slutsky, Arthur S ^a,b,c   Friedrich, Jan O ^b,c   Lee, Warren L ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CAUSE OF DEATH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; FLUID BALANCE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE SYSTEM; LEUKOCYTE; MORTALITY; NONHUMAN; PATHOGENESIS; SEPSIS; TIME OF DEATH; CLINICAL TRIAL (TOPIC); CROSS INFECTION; PROCEDURES; TRENDS;

CAUSE OF DEATH; CLINICAL TRIALS AS TOPIC; CROSS INFECTION; HUMANS; SEPSIS;

EID: 84908060383     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0540-y     Document Type: Editorial

References (23)

1. Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, Bauer M, Riedemann NC: The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care 2011, 15:R183..
2. Riedemann NC, Guo R-F, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003, 9:517-524. 10.1038/nm0503-517, 12724763.
3. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013, 13:260-268. 10.1016/S1473-3099(13)70001-X, 23427891.
4. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 1995, 273:934-941. 10.1001/jama.1995.03520360048038, 7884952.
5. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658. 10.1056/NEJM198709103171101, 3306374.
6. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605. 10.1001/jama.2011.1829, 22187279.
7. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013, 13:862-874. 10.1038/nri3552, 24232462.
8. Payen D, Monneret G, Hotchkiss R: Immunotherapy - a potential new way forward in the treatment of sepsis. Crit Care 2013, 17:118..
9. Unsinger J, Kazama H, McDonough JS, Griffith TS, Hotchkiss RS, Ferguson TA. Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism. J Immunol 2010, 184:6766-6772. 10.4049/jimmunol.0904054, 20483771.
10. Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dünser MW. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009, 108:1841-1847. 10.1213/ane.0b013e318195e11d, 19448210.
11. Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014, 5:66-72. 10.4161/viru.26907, 24185508.
12. Singer M. Powering up failed organs. Am J Respir Crit Care Med 2007, 176:733-734. 10.1164/rccm.200707-964ED, 17914124.
13. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007, 35:2702-2708. 10.1097/01.CCM.0000295593.25106.C4, 18074472.
14. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. The Lancet 2002, 360:219-223. 10.1016/S0140-6736(02)09459-X.
15. Lee WL, Slutsky AS. Sepsis and endothelial permeability. N Engl J Med 2010, 363:689-691. 10.1056/NEJMcibr1007320, 20818861.
16. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL: Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011, 3:88ps25..
17. London NR, Zhu W, Bozza FA, Smith MCP, Greif DM, Sorensen LK, Chen L, Kaminoh Y, Chan AC, Passi SF, Day CW, Barnard DL, Zimmerman GA, Krasnow MA, Li DY: Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010, 2:23ra19..
18. Kümpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park J-K, Bockmeyer CL, Parikh SM, Pavenstadt H, Haller H, Shushakova N: The synthetic tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011, 15:R261..
19. Heart N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, DeBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575. 10.1056/NEJMoa062200.
20. Boyd JH, Forbes J, Nakada T-A, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011, 39:259-265. 10.1097/CCM.0b013e3181feeb15, 20975548.
21. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014, 371:84..
22. Riedemann NC, Guo R-F, Ward PA. The enigma of sepsis. J Clin Invest 2003, 112:460-467. 10.1172/JCI200319523, 12925683.
23. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, Reinke P, Volk H-D. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180:640-648. 10.1164/rccm.200903-0363OC, 19590022.